造口时放置补片预防造口旁疝的随机双盲多中心试验(GRECCAR 7)
GRECCAR 7 为法国 18 家医院的前瞻性随机双盲多中心试验,纳入首次结肠造口患者,比较造口时放置或不放置轻量单丝合成补片。24 个月时临床诊断造口旁疝率在无补片组为 28%、补片组为 31%(P=0.77),未能证实预防性补片可降低造口旁疝发生率。
要点
- 造口时预防性放置补片未降低 24 个月临床诊断造口旁疝率。
- 补片组与无补片组造口相关并发症相近,未见补片感染。
- 不推荐以经中央切口穿结肠的腹膜后补片放置方式预防造口旁疝。
核心结论
- 本研究未能证明预防性补片放置可有效降低造口旁疝发生率。
- 以中央切口允许结肠通过的腹膜后补片放置方式不能推荐用于预防造口旁疝。
- 需优化补片位置与加强材料后进一步研究。
研究设计与样本
- 法国 18 家医院的前瞻性、随机、双盲、多中心试验。
- 纳入年龄≥18 岁、因非感染指征首次接受结肠造口的患者。
- 按中心分层、1:1 随机分为造口时放置或不放置轻量单丝合成补片组。
- 患者与结局评估者设盲,主要终点为意向治疗人群 24 个月临床诊断造口旁疝率。
- 试验注册号 NCT01380860。
主要发现
- 24 个月时无补片组(A 组)65 例、补片组(B 组)70 例,最常见脱落原因为死亡(n=41)。
- 24 个月时 A 组 28 例(28%)、B 组 30 例(31%)临床诊断造口旁疝[P=0.77,OR=1.15,95%CI(0.62;2.13)]。
- 造口相关并发症在 A 组 32 例、B 组 37 例报告,未见补片感染。
- 无与补片置入相关的死亡。
临床怎么用
- 不推荐以本试验所用腹膜后中央切口补片方式常规预防造口旁疝。
- 造口相关并发症与补片感染风险在本试验中未见明显增加。
局限性
- 24 个月时两组留存患者分别仅 65 例与 70 例,脱落较多,最常见原因为死亡(n=41)。
- 主要终点为临床诊断造口旁疝,未采用影像学诊断。
- 补片放置方式为腹膜后中央切口,结果不能推广至其他补片位置或材料。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether systematic mesh implantation upon primary colostomy creation was effective to prevent PSH. SUMMARY OF BACKGROUND DATA: Previous randomized trials on prevention of PSH by mesh placement have shown contradictory results. METHODS: This was a prospective, randomized controlled trial in 18 hospitals in France on patients aged ≥18 receiving a first colostomy for an indication other than infection. Participants were randomized by blocks of random size, stratified by center in a 1:1 ratio to colostomy with or without a synthetic, lightweight monofilament mesh. Patients and outcome assessors were blinded to patient group. The primary endpoint was clinically diagnosed PSH rate at 24 months of the intention-to-treat population. This trial was registered at ClinicalTrials.gov, number NCT01380860. RESULTS: From November 2012 to October 2016, 200 patients were enrolled. Finally, 65 patients remained in the no mesh group (Group A) and 70 in the mesh group (Group B) at 24 months with the most common reason for drop-out being death (n = 41). At 24 months, PSH was clinically detected in 28 patients (28%) in Group A and 30 (31%) in Group B [P = 0.77, odds ratio = 1.15 95% confidence interval = (0.62;2.13)]. Stoma-related complications were reported in 32 Group A patients and 37 Group B patients, but no mesh infections. There were no deaths related to mesh insertion. CONCLUSION: We failed to show efficiency of a prophylactic mesh on PSH rate. Placement of a mesh in a retro-muscular position with a central incision to allow colon passage cannot be recommended to prevent PSH. Optimization of mesh location and reinforcement material should be performed.
引用
- Prudhomme M, Rullier E, Lakkis Z, et al. End Colostomy With or Without Mesh to Prevent a Parastomal Hernia (GRECCAR 7): A Prospective, Randomized, Double Blinded, Multicentre Trial. Ann Surg. 2021. PMID: 33201089. doi:10.1097/SLA.0000000000004371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。